Curated industry list

High-Beta Momentum in Pharmaceuticals on NASDAQ

Explore High-Beta Momentum in Pharmaceuticals on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Cumberland Pharmaceuticals Inc (CPIX)
Fair Value-15.0% Downside Fair Market Cap122.9 M P/E Yield19.8% HealthGood
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Hyperion DeFi Inc (HYPD)
Fair Value0.2% Upside Fair Analyst146.2% Upside Market Cap62.002 M P/E Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Momentum
Cybin Inc (HELP)
Fair Value-20.2% Downside Overvalued Analyst193.4% Upside Market Cap1.002 B P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
GH Research PLC (GHRS)
Fair Value-19.3% Downside Overvalued Analyst53.9% Upside Market Cap1.912 B P/E Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Aardvark Therapeutics Inc (AARD)
Fair Value2.9% Upside Fair Analyst93.2% Upside Market Cap125.8 M P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
NervGen Pharma Corp (NGEN)
Fair Value-3.0% Downside Fair Analyst385.4% Upside Market Cap222 M P/E Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
Explore listed stocks on NASDAQ with company information and fair value data.